The role of proopiomelanocortin (POMC) neurones in feeding behaviour

The precursor protein, proopiomelanocortin (POMC), produces many biologically active peptides via a series of enzymatic steps in a tissue-specific manner, yielding the melanocyte-stimulating hormones (MSHs), corticotrophin (ACTH) and β-endorphin. The MSHs and ACTH bind to the extracellular G-protein coupled melanocortin receptors (MCRs) of which there are five subtypes. The MC3R and MC4R show widespread expression in the central nervous system (CNS), whilst there is low level expression of MC1R and MC5R. In the CNS, cell bodies for POMC are mainly located in the arcuate nucleus of the hypothalamus and the nucleus tractus solitarius of the brainstem. Both of these areas have well defined functions relating to appetite and food intake. Mouse knockouts (ko) for pomc, mc4r and mc3r all show an obese phenotype, as do humans expressing mutations of POMC and MC4R. Recently, human subjects with specific mutations in β-MSH have been found to be obese too, as have mice with engineered β-endorphin deficiency. The CNS POMC system has other functions, including regulation of sexual behaviour, lactation, the reproductive cycle and possibly central cardiovascular control. However, this review will focus on feeding behaviour and link it in with the neuroanatomy of the POMC neurones in the hypothalamus and brainstem.

[1]  R. Young,et al.  Proopiomelanocortin is the predominant adrenocorticotropin-related peptide in human cerebrospinal fluid. , 1993, The Journal of clinical endocrinology and metabolism.

[2]  G. Kilroy,et al.  Targeted deletion of melanocortin receptor subtypes 3 and 4, but not CART, alters nutrient partitioning and compromises behavioral and metabolic responses to leptin , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  D. Vishnuvardhan,et al.  Obliteration of α‐melanocyte‐stimulating hormone derived from POMC in pituitary and brains of PC2‐deficient mice , 2003, Journal of neurochemistry.

[4]  P. J. Larsen,et al.  Ups and downs for neuropeptides in body weight homeostasis: pharmacological potential of cocaine amphetamine regulated transcript and pre-proglucagon-derived peptides. , 2002, European journal of pharmacology.

[5]  R. Niaura,et al.  Nicotine replacement therapy , 2006, Journal of General Internal Medicine.

[6]  Robert A. McGovern,et al.  Divergence of Melanocortin Pathways in the Control of Food Intake and Energy Expenditure , 2005, Cell.

[7]  G. Pelletier,et al.  Demonstration of contacts between proopiomelanocortin neurons in the rat hypothalamus , 1983, Neuroscience Letters.

[8]  P. Svenningsson,et al.  Caffeine-induced expression of c-fos mRNA and NGFI-A mRNA in caudate putamen and in nucleus accumbens are differentially affected by the N-methyl-D-aspartate receptor antagonist MK-801. , 1996, Brain research. Molecular brain research.

[9]  S. O’Rahilly,et al.  A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance. , 2006, Cell metabolism.

[10]  L. Bellinger,et al.  The Dorsomedial Hypothalamic Nucleus Revisited: 1998 Update , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[11]  P. Poulain,et al.  Direct Inhibitory Action of Galanin on Hypothalamic Arcuate Nucleus Neurones Expressing Galanin Receptor Gal-R1 mRNA , 2003, Neuroendocrinology.

[12]  J. Morley,et al.  Dynorphin-(1-13) induces spontaneous feeding in rats. , 1981, Life sciences.

[13]  A. von Deimling,et al.  A role for beta-melanocyte-stimulating hormone in human body-weight regulation. , 2006, Cell metabolism.

[14]  S. Hisano,et al.  Synaptic association between enkephalin-containing axon terminals and proopiomelanocortin-containing neurons in the arcuate nucleus of rat hypothalamus , 1987, Neuroscience Letters.

[15]  Yue Feng,et al.  Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass , 2000, Nature Genetics.

[16]  J. Michaud,et al.  Development of neuroendocrine lineages requires the bHLH-PAS transcription factor SIM1. , 1998, Genes & development.

[17]  Y. Chagnon,et al.  Melanocortin-4 receptor gene and physical activity in the Québec Family Study , 2005, International Journal of Obesity.

[18]  R. Cone Anatomy and regulation of the central melanocortin system , 2005, Nature Neuroscience.

[19]  M. Dallman,et al.  Disruption of Arcuate/Paraventricular Nucleus Connections Changes Body Energy Balance and Response to Acute Stress , 2000, The Journal of Neuroscience.

[20]  F. Ashcroft,et al.  Electrical Inhibition of Identified Anorexigenic POMC Neurons by Orexin/Hypocretin , 2007, The Journal of Neuroscience.

[21]  R. Steiner,et al.  Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. , 1997, Endocrinology.

[22]  A. G. Roseberry,et al.  Neuropeptide Y-Mediated Inhibition of Proopiomelanocortin Neurons in the Arcuate Nucleus Shows Enhanced Desensitization in ob/ob Mice , 2004, Neuron.

[23]  R. Steiner,et al.  Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. , 1997, Endocrinology.

[24]  S. Bloom,et al.  Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/en.2003-0149 Identification of Hypothalamic Nuclei Involved in the Orexigenic Effect of Melanin-Concentrating Hormone , 2022 .

[25]  R. Cone,et al.  Agouti and Agouti-related Protein: Analogies and Contrasts* , 2000, The Journal of Biological Chemistry.

[26]  S. O’Rahilly,et al.  A de novo mutation affecting human TrkB associated with severe obesity and developmental delay , 2004, Nature Neuroscience.

[27]  P. Prusis,et al.  Binding of cyclic and linear MSH core peptides to the melanocortin receptor subtypes. , 1997, European journal of pharmacology.

[28]  J. M. de Castro,et al.  Food intake and meal patterns of weight-stable and weight-gaining persons. , 2002, The American journal of clinical nutrition.

[29]  A. Zinn,et al.  Sim1 haploinsufficiency impairs melanocortin-mediated anorexia and activation of paraventricular nucleus neurons. , 2006, Molecular endocrinology.

[30]  H. Jackson,et al.  Are δ-opioid receptors involved in the regulation of food and water intake? , 1985, Neuropharmacology.

[31]  X. Bertagna Proopiomelanocortin-derived peptides. , 1994, Endocrinology and metabolism clinics of North America.

[32]  J. Buckingham,et al.  Thymic peptides and neuroendocrine-immune communication. , 1992, The Journal of endocrinology.

[33]  Kanji A. Takahashi,et al.  Fasting induces a large, leptin-dependent increase in the intrinsic action potential frequency of orexigenic arcuate nucleus neuropeptide Y/Agouti-related protein neurons. , 2005, Endocrinology.

[34]  M. Brownstein,et al.  alpha MSH-like peptides in rat brain: identification and changes in level during development. , 1980, Biochemical and biophysical research communications.

[35]  R. Cone,et al.  Ala67Thr polymorphism in the Agouti‐related peptide gene is associated with inherited leanness in humans , 2004, American journal of medical genetics. Part A.

[36]  G. Barsh,et al.  Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. , 1997, Science.

[37]  N. Martin,et al.  Abnormalities of the hypothalamo-pituitary-thyroid axis in the pro-opiomelanocortin deficient mouse , 2004, Regulatory Peptides.

[38]  W. Millington,et al.  Alpha-melanocyte-stimulating hormone and N-acetyl-beta-endorphin immunoreactivities are localized in the human pituitary but are not restricted to the zona intermedia. , 1994, Endocrinology.

[39]  H. Münzberg,et al.  N-acetylation of hypothalamic α-melanocyte-stimulating hormone and regulation by leptin , 2004 .

[40]  M. Low,et al.  Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus , 2001, Nature.

[41]  N. Hilschmann,et al.  Human protein NEFA, a novel DNA binding/EF-hand/leucine zipper protein. Molecular cloning and sequence analysis of the cDNA, isolation and characterization of the protein. , 1994, Biological chemistry Hoppe-Seyler.

[42]  S. Woods,et al.  Role of the CNS Melanocortin System in the Response to Overfeeding , 1999, The Journal of Neuroscience.

[43]  L. Pannell,et al.  Carboxypeptidase E Is a Regulated Secretory Pathway Sorting Receptor: Genetic Obliteration Leads to Endocrine Disorders in Cpefat Mice , 1997, Cell.

[44]  K. Seo,et al.  Effect of capsaicin on cholecystokinin and neuropeptide Y expressions in the brain of high-fat diet fed rats. , 2004, The Journal of veterinary medical science.

[45]  E. Hooghe-Peters,et al.  Cafeteria diet-induced obese rats have an increased somatostatin protein content and gene expression in the periventricular nucleus , 1997, Journal of endocrinological investigation.

[46]  G. Millington Proopiomelanocortin (POMC): the cutaneous roles of its melanocortin products and receptors , 2006, Clinical and experimental dermatology.

[47]  Christopher P Austin,et al.  A role for the melanocortin 4 receptor in sexual function , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[48]  T. Miyoshi,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Melanin-Concentrating Hormone Acutely Stimulates Feeding, But Chronic Administration Has No Effect on , 2022 .

[49]  A. Ferguson,et al.  Making Sense of It: Roles of the Sensory Circumventricular Organs in Feeding and Regulation of Energy Homeostasis , 2007, Experimental biology and medicine.

[50]  V Bassareo,et al.  Differential Influence of Associative and Nonassociative Learning Mechanisms on the Responsiveness of Prefrontal and Accumbal Dopamine Transmission to Food Stimuli in Rats Fed Ad Libitum , 1997, The Journal of Neuroscience.

[51]  R. Cone,et al.  Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice , 1997, Cell.

[52]  R. Cone,et al.  A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. , 2000, Endocrinology.

[53]  Michael Davis,et al.  Neurotransmission in the rat amygdala related to fear and anxiety , 1994, Trends in Neurosciences.

[54]  B. Roland,et al.  The paraventricular nucleus of the hypothalamus and the functional neuroanatomy of visceromotor responses to stress. , 1996, Progress in brain research.

[55]  M. Ghatei,et al.  Hypothalamic Interactions Between Neuropeptide Y, Agouti‐Related Protein, Cocaine‐ and Amphetamine‐Regulated Transcript and Alpha‐Melanocyte‐Stimulating Hormone In Vitro in Male Rats , 2002, Journal of neuroendocrinology.

[56]  H. Vaudry,et al.  Expression of Melanocortin MC3 and MC4 Receptor mRNAs by Neuropeptide Y Neurons in the Rat Arcuate Nucleus , 2006, Neuroendocrinology.

[57]  A. Fournier,et al.  Regulation of proopiomelanocortin gene expression by neuropeptide Y in the rat arcuate nucleus , 1995, Brain Research.

[58]  Thorsten Buch,et al.  Agouti-related peptide–expressing neurons are mandatory for feeding , 2005, Nature Neuroscience.

[59]  R. Mains,et al.  The prohormone convertases PC1 and PC2 mediate distinct endoproteolytic cleavages in a strict temporal order during proopiomelanocortin biosynthetic processing. , 1993, The Journal of biological chemistry.

[60]  W. Rand,et al.  α-Melanocyte stimulating hormone prevents fasting-induced suppression of corticotropin-releasing hormone gene expression in the rat hypothalamic paraventricular nucleus , 2000, Neuroscience Letters.

[61]  F. Fujiyama,et al.  Plasma membrane and vesicular glutamate transporter mRNAs/proteins in hypothalamic neurons that regulate body weight , 2003, The European journal of neuroscience.

[62]  D. Vieau,et al.  Distinct mRNA expression of the highly homologous convertases PC5 and PACE4 in the rat brain and pituitary , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[63]  Richard P. Woychik,et al.  Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor , 1994, Nature.

[64]  M. Mori,et al.  Identification of nesfatin-1 as a satiety molecule in the hypothalamus , 2006, Nature.

[65]  J. Kiss,et al.  Glutamatergic innervation of neuropeptide Y and pro‐opiomelanocortin‐containing neurons in the hypothalamic arcuate nucleus of the rat , 2005, The European journal of neuroscience.

[66]  S. Bouret,et al.  Formation of Projection Pathways from the Arcuate Nucleus of the Hypothalamus to Hypothalamic Regions Implicated in the Neural Control of Feeding Behavior in Mice , 2004, The Journal of Neuroscience.

[67]  M. Aubert,et al.  The Melanocortin Agonist Melanotan‐II Reduces the Orexigenic and Adipogenic Effects of Neuropeptide Y (NPY) but Does not Affect the NPY‐Driven Suppressive Effects on the Gonadotropic and Somatotropic Axes in the Male Rat , 2003, Journal of neuroendocrinology.

[68]  R. Cone,et al.  Melanocortin-4 receptor is required for acute homeostatic responses to increased dietary fat , 2001, Nature Neuroscience.

[69]  J. Wikberg,et al.  Differential effects of melanocortin peptides on ingestive behaviour in rats: evidence against the involvement of MC3 receptor in the regulation of food intake , 2000, Neuroscience Letters.

[70]  S. O’Rahilly,et al.  Proopiomelanocortin and energy balance: insights from human and murine genetics. , 2004, The Journal of clinical endocrinology and metabolism.

[71]  T. Bartness,et al.  Agouti-related protein increases food hoarding more than food intake in Siberian hamsters. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[72]  Irina Stoyanova,et al.  Peptides that regulate food intake: appetite-inducing accumbens manipulation activates hypothalamic orexin neurons and inhibits POMC neurons. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[73]  Juan I. Young,et al.  A Role for the Endogenous Opioid -Endorphin in Energy Homeostasis , 2003 .

[74]  L. Yaswen,et al.  Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin , 1999, Nature Medicine.

[75]  S. O’Rahilly,et al.  A comparative study of the central effects of specific proopiomelancortin (POMC)-derived melanocortin peptides on food intake and body weight in pomc null mice. , 2006, Endocrinology.

[76]  K. Koyano,et al.  Leptin modulates behavioral responses to sweet substances by influencing peripheral taste structures. , 2004, Endocrinology.

[77]  H. Vaudry,et al.  Melanocortin‐3 Receptor mRNA Expression in Pro‐Opiomelanocortin Neurones of the Rat Arcuate Nucleus , 2000, Journal of neuroendocrinology.

[78]  A. Sclafani,et al.  Paraventricular hypothalamic lesions and medial hypothalamic knife cuts produce similar hyperphagia syndromes. , 1983, Behavioral neuroscience.

[79]  D. Smith,et al.  Effects of Melanocortin Receptor Ligands on Thyrotropin‐Releasing Hormone Release: Evidence for the Differential Roles of Melanocortin 3 and 4 Receptors , 2002, Journal of neuroendocrinology.

[80]  A. Butler,et al.  Double leptin and melanocortin-4 receptor gene mutations have an additive effect on fat mass and are associated with reduced effects of leptin on weight loss and food intake. , 2005, Endocrinology.

[81]  R. Cone,et al.  Characterization of the neuroanatomical distribution of agouti-related protein immunoreactivity in the rhesus monkey and the rat. , 1999, Endocrinology.

[82]  L. Almasy,et al.  Normal variation in leptin levels in associated with polymorphisms in the proopiomelanocortin gene, POMC. , 1999, The Journal of clinical endocrinology and metabolism.

[83]  Philippe Froguel,et al.  Intracellular retention is a common characteristic of childhood obesity-associated MC4R mutations. , 2003, Human molecular genetics.

[84]  H. Münzberg,et al.  Role of signal transducer and activator of transcription 3 in regulation of hypothalamic proopiomelanocortin gene expression by leptin. , 2003, Endocrinology.

[85]  B. Kieffer Opioids: first lessons from knockout mice. , 1999, Trends in pharmacological sciences.

[86]  Victor J. Hruby,et al.  Role of melanocortinergic neurons in feeding and the agouti obesity syndrome , 1997, Nature.

[87]  M. Tschöp,et al.  A role for β-melanocyte-stimulating hormone in human body-weight regulation , 2006 .

[88]  G. Barsh,et al.  Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area , 1998, The Journal of comparative neurology.

[89]  Juan I. Young,et al.  A role for the endogenous opioid beta-endorphin in energy homeostasis. , 2003, Endocrinology.

[90]  G. Luheshi,et al.  The Role of the Vagus Nerve in Mediating the Long‐Term Anorectic Effects of Leptin , 2007, Journal of neuroendocrinology.

[91]  P. Lambert,et al.  Additive effects of lactation and food restriction to increase hypothalamic neuropeptide Y mRNA in rats. , 1997, The Journal of endocrinology.

[92]  S. Bouret,et al.  Trophic Action of Leptin on Hypothalamic Neurons That Regulate Feeding , 2004, Science.

[93]  R. G. Allen,et al.  Post-translational processing of pro-opiomelanocortin (POMC)-derived peptides during fetal monkey pituitary development. I. Adrenocorticotropin (ACTH) and alpha-melanotropins (alpha-MSHs). , 1988, Developmental biology.

[94]  H. Anisman,et al.  Aversive and Appetitive Events Evoke the Release of Corticotropin-Releasing Hormone and Bombesin-Like Peptides at the Central Nucleus of the Amygdala , 1998, The Journal of Neuroscience.

[95]  A. Turnbull,et al.  Proopiomelanocortin-derived peptides in rat cerebrospinal fluid and hypothalamic extracts: evidence that secretion is regulated with respect to energy balance. , 2003, Endocrinology.

[96]  Mohammad A Ghatei,et al.  Inhibition of food intake in obese subjects by peptide YY3-36. , 2003, The New England journal of medicine.

[97]  J. Beauvillain,et al.  Semiquantitative distribution of galanin-receptor (GAL-R1) mRNA-containing cells in the male rat hypothalamus. , 1997, Neuroendocrinology.

[98]  S. Woods,et al.  Effect of intracerebroventricular alpha-MSH on food intake, adiposity, c-Fos induction, and neuropeptide expression. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[99]  R. Cone,et al.  Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome. , 1997, Molecular endocrinology.

[100]  J. Hebebrand,et al.  Systematic mutation screening of the pro-opiomelanocortin gene: identification of several genetic variants including three different insertions, one nonsense and two missense point mutations in probands of different weight extremes. , 1998, The Journal of clinical endocrinology and metabolism.

[101]  M. G. Dube,et al.  Food intake elicited by central administration of orexins/hypocretins: identification of hypothalamic sites of action 1 This study was presented in part at the 28th Annual Meeting of the Society for Neuroscience, Los Angeles, CA, in November 1998. 1 , 1999, Brain Research.

[102]  S. O’Rahilly,et al.  Differential effects of α-, β- and γ2-melanocyte-stimulating hormones on hypothalamic neuronal activation and feeding in the fasted rat , 2001, Neuroscience.

[103]  D. Porte,et al.  Diabetes, Obesity, and the Brain , 2005, Science.

[104]  A. Levine,et al.  Injection of alpha-MSH, but not beta-endorphin, into the PVN decreases POMC gene expression in the ARC. , 2002, Neuroreport.

[105]  J. Shutter,et al.  Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. , 1997, Genes & development.

[106]  Y. Loh,et al.  Purification and characterization of a paired basic residue-specific pro-opiomelanocortin converting enzyme from bovine pituitary intermediate lobe secretory vesicles. , 1985, The Journal of biological chemistry.

[107]  A. Guidotti,et al.  Stimulation of food intake by muscimol and beta endorphin , 1977, Neuropharmacology.

[108]  D. Swaab,et al.  Attenuation of the polypeptide 7B2, prohormone convertase PC2, and vasopressin in the hypothalamus of some Prader-Willi patients: indications for a processing defect. , 1998, The Journal of clinical endocrinology and metabolism.

[109]  R. Palmiter,et al.  Response of melanocortin–4 receptor–deficient mice to anorectic and orexigenic peptides , 1999, Nature Genetics.

[110]  S. Getting,et al.  Targeting melanocortin receptors as potential novel therapeutics. , 2006, Pharmacology & therapeutics.

[111]  C. Priest,et al.  Hypothalamic Pro-Opiomelanocortin mRNA Is Reduced By Fasting in ob/ob and db/db Mice, but Is Stimulated by Leptin , 1998, Diabetes.

[112]  C. Saper,et al.  Distributions of leptin receptor mRNA isoforms in the rat brain , 1998, The Journal of comparative neurology.

[113]  H. Grill,et al.  Printed in U.S.A. Copyright © 2002 by The Endocrine Society Evidence That the Caudal Brainstem Is a Target for the Inhibitory Effect of Leptin on Food Intake , 2022 .

[114]  angesichts der Corona-Pandemie,et al.  UPDATE , 1973, The Lancet.

[115]  R. Mains,et al.  Peptide biosynthetic processing: distinguishing prohormone convertases PC1 and PC2 , 1996, Molecular and Cellular Endocrinology.

[116]  H. Mo,et al.  A novel and selective beta-melanocyte-stimulating hormone-derived peptide agonist for melanocortin 4 receptor potently decreased food intake and body weight gain in diet-induced obese rats. , 2005, Endocrinology.

[117]  A. N. van den Pol,et al.  Synaptic Interaction between Hypocretin (Orexin) and Neuropeptide Y Cells in the Rodent and Primate Hypothalamus: A Novel Circuit Implicated in Metabolic and Endocrine Regulations , 1999, The Journal of Neuroscience.

[118]  S. Sarkar,et al.  GABAergic agents prevent alpha-melanocyte stimulating hormone induced anxiety and anorexia in rats , 2003, Pharmacology Biochemistry and Behavior.

[119]  M. Therrien,et al.  Tissue-specific activity of the pro-opiomelanocortin (POMC) gene and repression by glucocorticoids. , 1989, Genome.

[120]  H. Vaudry,et al.  Interrelations between Hypothalamic Somatostatin and Proopiomelanocortin Neurons , 1998, Journal of neuroendocrinology.

[121]  J. Brobeck,et al.  Localization of a “Feeding Center” in the Hypothalamus of the Rat , 1951, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[122]  A. Weindl,et al.  The morphology of LRH and oxytocin neurons. , 1981, Experimental brain research.

[123]  S. O’Rahilly,et al.  Monogenic human obesity syndromes. , 2004, Recent progress in hormone research.

[124]  T. W. Bailey,et al.  Proopiomelanocortin Neurons in Nucleus Tractus Solitarius Are Activated by Visceral Afferents: Regulation by Cholecystokinin and Opioids , 2005, The Journal of Neuroscience.

[125]  S. Woods,et al.  Central nervous system control of food intake , 2000, Nature.

[126]  A. G. Roseberry,et al.  Transgenic Mice Expressing Green Fluorescent Protein under the Control of the Melanocortin-4 Receptor Promoter , 2003, The Journal of Neuroscience.

[127]  R. Cone,et al.  Peptide YY3-36 inhibits food intake in mice through a melanocortin-4 receptor-independent mechanism. , 2004, Endocrinology.

[128]  Joseph E LeDoux,et al.  Organization of intra-amygdaloid circuitries in the rat: an emerging framework for understanding functions of the amygdala , 1997, Trends in Neurosciences.

[129]  Malcolm J. Low,et al.  Identification of Neuronal Enhancers of the Proopiomelanocortin Gene by Transgenic Mouse Analysis and Phylogenetic Footprinting , 2005, Molecular and Cellular Biology.

[130]  R. Seeley,et al.  A Novel Selective Melanocortin-4 Receptor Agonist Reduces Food Intake in Rats and Mice without Producing Aversive Consequences , 2000, The Journal of Neuroscience.

[131]  A. Kelley,et al.  Nucleus Accumbens μ-Opioids Regulate Intake of a High-Fat Diet via Activation of a Distributed Brain Network , 2003, The Journal of Neuroscience.

[132]  L. Pérusse,et al.  Genotype-environment interaction in human obesity. , 2009, Nutrition reviews.

[133]  K. Clément,et al.  A frameshift mutation in human MC4R is associated with a dominant form of obesity , 1998, Nature Genetics.

[134]  C. Boozer,et al.  VGF is Required for Obesity Induced by Diet, Gold Thioglucose Treatment, and Agouti and is Differentially Regulated in Pro-Opiomelanocortin- and Neuropeptide Y-Containing Arcuate Neurons in Response to Fasting , 2002, The Journal of Neuroscience.

[135]  L. H. Haley,et al.  Mapping of genes and transcribed sequences in a gene rich 400-kb region on human chromosome 11p15.1→p14 , 2001, Cytogenetic and Genome Research.

[136]  M. Mortrud,et al.  Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. , 1994, Molecular endocrinology.

[137]  R. G. Allen,et al.  Post-translational processing of pro-opiomelanocortin (POMC)-derived peptides during fetal monkey pituitary development: II. β-lipotropin (β-LPH)-related peptides☆ , 1988 .

[138]  W. Banks,et al.  Characterization of Blood-Brain Barrier Permeability to PYY3-36 in the Mouse , 2003, Journal of Pharmacology and Experimental Therapeutics.

[139]  C. Fekete,et al.  Neuroanatomical evidence for participation of the hypothalamic dorsomedial nucleus (DMN) in regulation of the hypothalamic paraventricular nucleus (PVN) by α-melanocyte stimulating hormone , 2005, Brain Research.

[140]  G. Baldini,et al.  Constitutive Traffic of Melanocortin-4 Receptor in Neuro2A Cells and Immortalized Hypothalamic Neurons* , 2007, Journal of Biological Chemistry.

[141]  A. Yamanaka,et al.  Orexins (hypocretins) directly interact with neuropeptide Y, POMC and glucose‐responsive neurons to regulate Ca2+ signaling in a reciprocal manner to leptin: orexigenic neuronal pathways in the mediobasal hypothalamus , 2004, The European journal of neuroscience.

[142]  K. Hosoda,et al.  Pathophysiological significance of the obese gene product, leptin, in ventromedial hypothalamus (VMH)-lesioned rats: evidence for loss of its satiety effect in VMH-lesioned rats. , 1997, Endocrinology.

[143]  N. Seidah,et al.  The cDNA structure of the porcine pro‐hormone convertase PC2 and the comparative processing by PC1 and PC2 of the N‐terminal glycopeptide segment of porcine POMC , 1992, FEBS letters.

[144]  G. Barsh,et al.  Anatomy of an Endogenous Antagonist: Relationship between Agouti-Related Protein and Proopiomelanocortin in Brain , 1999, The Journal of Neuroscience.

[145]  John Blangero,et al.  A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2 , 1997, Nature Genetics.

[146]  G. Barsh,et al.  Behavioral / Systems / Cognitive Interaction between-Melanocyte-Stimulating Hormone and Corticotropin-Releasing Hormone in the Regulation of Feeding and Hypothalamo-Pituitary-Adrenal Responses , 2003 .

[147]  P. Morgan,et al.  Photoperiodic regulation of histamine H3 receptor and VGF messenger ribonucleic acid in the arcuate nucleus of the Siberian hamster. , 2005, Endocrinology.

[148]  Kanji A. Takahashi,et al.  Cholecystokinin-mediated suppression of feeding involves the brainstem melanocortin system , 2004, Nature Neuroscience.

[149]  M. Cowley,et al.  The electrophysiology of feeding circuits , 2004, Trends in Endocrinology & Metabolism.

[150]  Sandra D. O'Dell,et al.  Evidence of multiple causal sites affecting weight in the IGF2-INS-TH region of human chromosome 11 , 2002, Human Genetics.

[151]  M. Hulver,et al.  Diet-genotype interactions in the development of the obese, insulin-resistant phenotype of C57BL/6J mice lacking melanocortin-3 or -4 receptors. , 2006, Endocrinology.

[152]  C. Priest,et al.  Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting and [corrected] in ob/ob and db/db mice, but is stimulated by leptin. , 1998, Diabetes.

[153]  N. Seidah,et al.  Distribution and regulation of the prohormone convertases PC1 and PC2 in the rat pituitary. , 1992, Molecular endocrinology.

[154]  S. O’Rahilly,et al.  Acute effects of PYY3-36 on food intake and hypothalamic neuropeptide expression in the mouse. , 2003, Biochemical and biophysical research communications.

[155]  A. G. Roseberry,et al.  Rapid Rewiring of Arcuate Nucleus Feeding Circuits by Leptin , 2004, Science.

[156]  Bruce M. Spiegelman,et al.  Obesity and the Regulation of Energy Balance , 2001, Cell.

[157]  R. Cone,et al.  PYY3-36 inhibits the action potential firing activity of POMC neurons of arcuate nucleus through postsynaptic Y2 receptors. , 2005, Cell metabolism.

[158]  M. Mattson,et al.  Reversal of behavioral and metabolic abnormalities, and insulin resistance syndrome, by dietary restriction in mice deficient in brain-derived neurotrophic factor. , 2003, Endocrinology.

[159]  R. Cone,et al.  The Central Melanocortin System and Energy Homeostasis , 1999, Trends in Endocrinology & Metabolism.

[160]  S. Bhattacharyya,et al.  A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism. , 2002, Human molecular genetics.

[161]  H. Davidowa,et al.  Food deprivation decreases responsiveness of ventromedial hypothalamic neurons to melanocortins , 2004, Journal of neuroscience research.

[162]  H. Münzberg,et al.  N-acetylation of hypothalamic alpha-melanocyte-stimulating hormone and regulation by leptin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[163]  R. Adan,et al.  AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor. , 2001, Molecular endocrinology.

[164]  L. Gillberg,et al.  Hypothalamic proopiomelanocortin (POMC) neurons have a cholinergic phenotype , 2006, The European journal of neuroscience.

[165]  H. Christian,et al.  Perinatal glucocorticoid treatment produces molecular, functional, and morphological changes in the anterior pituitary gland of the adult male rat. , 2005, Endocrinology.

[166]  Sarah Stanley,et al.  Hormonal regulation of food intake. , 2005, Physiological reviews.

[167]  S. Woods,et al.  Learned meal initiation attenuates the anorexic effects of the melanocortin agonist MTII. , 2003, Diabetes.

[168]  T. Bártfai,et al.  Galanin--10 years with a neuroendocrine peptide. , 1995, The international journal of biochemistry & cell biology.

[169]  J. Flier Obesity Wars Molecular Progress Confronts an Expanding Epidemic , 2004, Cell.

[170]  H. Grill,et al.  Divergent regulation of proopiomelanocortin neurons by leptin in the nucleus of the solitary tract and in the arcuate hypothalamic nucleus. , 2006, Diabetes.

[171]  Rachel L. Batterham,et al.  Gut hormone PYY3-36 physiologically inhibits food intake , 2002, Nature.

[172]  Min-Seon Kim,et al.  Investigation of the melanocyte stimulating hormones on food intake Lack of evidence to support a role for the melanocortin-3-receptor , 2000, Brain Research.

[173]  R. Cone,et al.  A Unique Metalolic Sysdrone Causes Obesity in the Melanocortin-3 Receptor-Deficient Mouse. , 2000, Endocrinology.

[174]  Mitsuru Nishiyama,et al.  GABA Release from Proopiomelanocortin Neurons , 2004, The Journal of Neuroscience.

[175]  J Dixon,et al.  Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36). , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[176]  R. Adan,et al.  Poor Cell Surface Expression of Human Melanocortin-4 Receptor Mutations Associated with Obesity* , 2003, Journal of Biological Chemistry.

[177]  R. G. Allen,et al.  Absence of opioid stress-induced analgesia in mice lacking beta-endorphin by site-directed mutagenesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[178]  A. Turnbull,et al.  Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity. , 2002, The Journal of endocrinology.

[179]  S. O’Rahilly,et al.  A frameshift mutation in MC4R associated with dominantly inherited human obesity , 1998, Nature Genetics.

[180]  L. E. Pritchard,et al.  Agouti-related protein: More than a melanocortin-4 receptor antagonist? , 2005, Peptides.

[181]  R. Skoda,et al.  Leptin Receptor Immunoreactivity in Chemically Defined Target Neurons of the Hypothalamus , 1998, The Journal of Neuroscience.

[182]  J. Born,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society The Melanocortin Melanocyte-Stimulating Hormone/Adrenocorticotropin 4–10 Decreases Body Fat in Humans* , 2022 .

[183]  A. Plagemann,et al.  Altered responses to orexigenic (AGRP, MCH) and anorexigenic (α‐MSH, CART) neuropeptides of paraventricular hypothalamic neurons in early postnatally overfed rats , 2003, The European journal of neuroscience.

[184]  H. Berthoud,et al.  Brain stem melanocortinergic modulation of meal size and identification of hypothalamic POMC projections. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[185]  J. M. Lipton,et al.  α-Melanocyte-stimulating Hormone in Normal Human Physiology and Disease States , 2000, Trends in Endocrinology & Metabolism.

[186]  C. Schalin-Jäntti,et al.  Melanocortin-3-receptor gene variants in morbid obesity , 2003, International Journal of Obesity.

[187]  A. Bateman,et al.  Post-translational modification of bovine pro-opiomelanocortin. Tyrosine sulfation and pyroglutamate formation, a mass spectrometric study. , 1990, The Journal of biological chemistry.

[188]  S. O’Rahilly,et al.  Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene , 1997, Nature Genetics.

[189]  L. Perrone,et al.  Weight loss in obese children carrying the proopiomelanocortin R236G variant , 2006, Journal of endocrinological investigation.

[190]  P. Lambert,et al.  The effect of central blockade of kappa-opioid receptors on neuropeptide Y-induced feeding in the rat , 1993, Brain Research.

[191]  E. H. Goulding,et al.  Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor , 2003, Nature Neuroscience.

[192]  M. Mortrud,et al.  Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[193]  R. G. Allen,et al.  The distribution of forms of adrenocorticotropin and beta-endorphin in normal, tumorous, and autopsy human anterior pituiary tissue: virtual absence of 13K adrenocorticotropin. , 1980, The Journal of clinical endocrinology and metabolism.